Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Nagata

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Respiratory Medicine|July 7, 2024
Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung diseaseKatsuyuki Furuta, Daichi Fujimoto, Atsushi Matsunashi, et al.
Respirology (Carlton, Vic.)|June 14, 2017
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacityYuki Sato, Daichi Fujimoto, Takeshi Morimoto, et al.
Therapeutic Advances in Infectious Disease|October 6, 2025
Changes in virus-related exacerbations of chronic respiratory diseases before and after the relaxation of COVID-19 infection control measures: a single-centre retrospective study in JapanTsuyoshi Sasada, Ryota Kishi, Chigusa Shirakawa, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumoniaDaichi Fujimoto, Takeshi Morimoto, Jiro Ito, et al.
BMC Cancer|February 8, 2020
Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective studyMariko Kogo, Daichi Fujimoto, Kazutaka Hosoya, et al.
Investigational New Drugs|November 5, 2022
Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrenceYusuke Shima, Yuki Sato, Takeshi Morimoto, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2019
Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patientsKazutaka Hosoya, Daichi Fujimoto, Hayato Kawachi, et al.
Annals of the American Thoracic Society|December 29, 2017
Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover TrialKazuma Nagata, Takashi Kikuchi, Takeo Horie, et al.
Acute Medicine & Surgery|May 24, 2021
Validation of National Early Warning Score for predicting 30-day mortality after rapid response system activation in JapanTakaki Naito, Kuniyoshi Hayashi, Hsiang-Chin Hsu, et al.
Respiration; International Review of Thoracic Diseases|September 14, 2011
Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathicRyo Tachikawa, Keisuke Tomii, Hiroyuki Ueda, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|July 7, 2024
Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung diseaseKatsuyuki Furuta, Daichi Fujimoto, Atsushi Matsunashi, et al.
Respirology (Carlton, Vic.)|June 14, 2017
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacityYuki Sato, Daichi Fujimoto, Takeshi Morimoto, et al.
Therapeutic Advances in Infectious Disease|October 6, 2025
Changes in virus-related exacerbations of chronic respiratory diseases before and after the relaxation of COVID-19 infection control measures: a single-centre retrospective study in JapanTsuyoshi Sasada, Ryota Kishi, Chigusa Shirakawa, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumoniaDaichi Fujimoto, Takeshi Morimoto, Jiro Ito, et al.
BMC Cancer|February 8, 2020
Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective studyMariko Kogo, Daichi Fujimoto, Kazutaka Hosoya, et al.
Investigational New Drugs|November 5, 2022
Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrenceYusuke Shima, Yuki Sato, Takeshi Morimoto, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2019
Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patientsKazutaka Hosoya, Daichi Fujimoto, Hayato Kawachi, et al.
Annals of the American Thoracic Society|December 29, 2017
Domiciliary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover TrialKazuma Nagata, Takashi Kikuchi, Takeo Horie, et al.
Acute Medicine & Surgery|May 24, 2021
Validation of National Early Warning Score for predicting 30-day mortality after rapid response system activation in JapanTakaki Naito, Kuniyoshi Hayashi, Hsiang-Chin Hsu, et al.
Respiration; International Review of Thoracic Diseases|September 14, 2011
Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathicRyo Tachikawa, Keisuke Tomii, Hiroyuki Ueda, et al.
Pageof 8